New York State Legislature Considers Ban on Flavored Nicotine Pouches

Feb.12
New York State Legislature Considers Ban on Flavored Nicotine Pouches
New York State Legislature is considering a ban on flavored nicotine pouches to curb underage tobacco use.

According to a report by Timesunion on February 11, the New York State Legislature is considering passing a bill to ban the sale of flavored nicotine pouches in the state. The ban is based on the belief that fruit and candy flavored products are a marketing tactic aimed at minors.


Congresswoman Linda Rosenthal has expressed concerns about the nicotine pouch brand ZYN, which offers flavors such as mint, citrus, and coffee. She pointed out that with flavored e-cigarettes becoming harder to find in New York, minors may turn to nicotine pouches.


Brian Erkkila, the Chief Scientific Officer of Swedish Match, stated that the main customer base of ZYN is not new nicotine users, but rather adults who are transitioning to safer products.


However, some experts believe that a comprehensive ban on the product may backfire. Raymond Niaura, a professor at New York University, stated that data shows the proportion of teenagers using the product is still very low, and he believes a ban is an "overreaction." Alan Mathios, a professor at Cornell University, also warned that a ban on flavored nicotine pouches could lead to the emergence of an illegal market, making it easier for teenagers to access such products.


On January 17, the U.S. FDA approved marketing authorization for 20 ZYN brand nicotine pouch products. This marks a significant milestone for the FDA in regulating novel tobacco products.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
Mexico Passes Law Banning Commercial Sale and Advertising of Vapes and E-Cigarettes
Mexico Passes Law Banning Commercial Sale and Advertising of Vapes and E-Cigarettes
Mexico’s Chamber of Deputies approved a constitutional reform prohibiting the production, import, export, transport, distribution, sale, and advertising of vapes and e-cigarettes nationwide. The law does not ban personal use of such products. Backed by President Claudia Sheinbaum, the amendment to the General Health Law imposes penalties of one to eight years in prison and fines between 11,314 and 226,280 pesos (approximately USD 621–12,430).
Dec.10 by 2FIRSTS.ai
Moroccan Government Rejects Opposition Proposal to Increase Excise Tax on E-Cigarettes
Moroccan Government Rejects Opposition Proposal to Increase Excise Tax on E-Cigarettes
Moroccan government has firmly rejected proposals from opposition parties to increase the internal consumption tax (TIC) on e-cigarettes and related products under the 2026 Finance Bill. Budget Minister Delegate Fouzi Lekjaa argued that raising excise duties would not reduce demand and would instead encourage smuggling. Opposition groups emphasized the growing health risks and rising popularity of vaping among young people.
Nov.13 by 2FIRSTS.ai
South Korea National Assembly Approves Bill to Regulate E-Cigarettes Under Tobacco Law After Nine Years of Debate
South Korea National Assembly Approves Bill to Regulate E-Cigarettes Under Tobacco Law After Nine Years of Debate
South Korea’s National Assembly Legislation and Judiciary Committee passed a long-debated amendment to the Tobacco Business Act on November 26, expanding the legal definition of tobacco to include synthetic nicotine e-cigarettes. The amendment aims to end the regulatory blind spot surrounding such products while ensuring transitional support for vape retailers and a grace period for compliance.
Nov.26 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgian Health Minister Frank Vandenbroucke has announced plans to ban all e-cigarette flavours except tobacco, following new advice from the Superior Health Council (CSS). The move marks a major policy shift, as the Council now fully supports flavour restrictions to curb youth vaping.
Nov.19 by 2FIRSTS.ai